Edward C. Saltzman - Sep 12, 2022 Form 3 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Christine Ring, as Attorney-in-Fact for Edward C. Saltzman
Stock symbol
NRIX
Transactions as of
Sep 12, 2022
Transactions value $
$0
Form type
3
Date filed
9/14/2022, 04:24 PM
Next filing
May 4, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.